EDESA BIOTECH, INC.

Profile

Company Names

EDESA BIOTECH, INC.
STELLAR BIOTECHNOLOGIES, INC.

Addresses

100 SPY COURT, MARKHAM, A6 L3R 5H6

332 EAST SCOTT STREET, PORT HUENEME, CA 93041

332 EAST SCOTT STREET, PORT HUNEMENE, CA 93041

Phone Numbers

289-800-9600
(805) 488-2800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$40,374,082.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2026-06-16 
$3,499,986.00 
$3,500,000.00 
$14.00 
Equity 
7
2025-02-12 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
6
2022-03-21 
$0.00 
INDEFINITE 
INDEFINITE 
 
5
2016-07-06 
$6,750,000.00 
$6,750,000.00 
$0.00 
 
4
2013-09-09 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
3
2013-04-03 
$1,613,700.00 
$1,613,700.00 
$0.00 
Equity 
2
2013-01-02 
$504,596.00 
$505,000.00 
$404.00 
Equity 
1
2012-10-25 
$1,005,800.00 
$1,005,800.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
 
BAXTER 
DIRECTOR
GREGORY 
T. 
BAXTER 
DIRECTOR
GREGORY 
TODD 
BAXTER 
DIRECTOR
MARY 
CATHERINE 
BRISSON 
EXECUTIVE OFFICER
DARRELL 
 
BROOKSTEIN 
EXECUTIVE OFFICER, DIRECTOR
DARRELL 
H. 
BROOKSTEIN 
EXECUTIVE OFFICER, DIRECTOR
JENNIFER 
 
CHAO 
DIRECTOR
TESSIE 
M. 
CHE 
DIRECTOR
HERBERT 
S. 
CHOW 
EXECUTIVE OFFICER
HERBERT 
SHUI-KEUNG 
CHOW 
EXECUTIVE OFFICER
JOAN 
 
CHYPYHA 
DIRECTOR
MALCOLM 
LAWRENCE 
GEFTER 
DIRECTOR
DAVID 
LOUIS 
HILL 
DIRECTOR
LORIN 
 
JOHNSON 
DIRECTOR
STEPHEN 
 
LEMIEUX 
EXECUTIVE OFFICER
DAVID 
 
LIU 
DIRECTOR
SEAN 
 
MACDONALD 
DIRECTOR
PATRICK 
 
MARSHALL 
DIRECTOR
MARK 
A. 
MCPARTLAND 
EXECUTIVE OFFICER
DANIEL 
 
MORSE 
DIRECTOR
DANIEL 
E. 
MORSE 
DIRECTOR
KATHI 
 
NIFFENEGGER 
EXECUTIVE OFFICER
PARDEEP 
 
NIJHAWAN 
EXECUTIVE OFFICER, DIRECTOR
FRANK 
 
OAKES 
DIRECTOR
FRANK 
R. 
OAKES 
EXECUTIVE OFFICER, DIRECTOR
CHARLES 
 
OLSON 
DIRECTOR
PAUL 
 
PAY 
DIRECTOR
MAYANK 
D. 
SAMPAT 
DIRECTOR
MAYANK 
DWARKADAS 
SAMPAT 
DIRECTOR
CARLO 
 
SISTILLI 
DIRECTOR
JOHN 
SIEVERT 
SUNDSMO 
EXECUTIVE OFFICER
PETER 
 
WEILER 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-06-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-02-12 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-03-21 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-07-06 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-09-09 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-04-03 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-01-02 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NA
NONE
MAXIM GROUP LLC
NEWPORT COAST SECURITIES, INC.
NEWPORT COAST SECURITIES, INC.